This partnership
is personal

Today’s genomic solutions for tomorrow’s cancer breakthroughs

Oncology

An expanding next-generation sequencing (NGS) oncology portfolio is helping Illumina drive the revolution in cancer genomics. Our NGS and microarray technologies are among the most trusted in the world. Our sample-to-data solutions deliver high-quality, reproducible results to speed the discovery and analysis of cancer-related variants—and potentially transform the cancer care cycle.

We’re committed to advancing and individualizing the way cancer will be identified and treated. We want to partner with you in helping propel progress in personalized oncology. Together we can work toward achieving our ultimate goal: to make discoveries that will make a life-changing difference to cancer patients and their loved ones.

Oncology
Image
Cancer Genomics Research

Keep ahead of the genomics technology curve to improve the quality of your research.

Investigate
Image
Pathology & Clinical Cancer Research

Expand your sequencing capabilities—and the accuracy and potential impact of your lab.

Explore
Image
Future of NGS in Oncology

See how NGS might help improve cancer treatment and outcomes.

Learn
Image
Cancer Companion Diagnostics

Enhance the power and promise of your companion diagnostics capabilities.

Experience
Image